TiGenix amends follow-on

TiGenix N.V. (Euronext:TIG), Leuven, Belgium Business: Gene/Cell therapy, Autoimmune, Musculoskeletal Date announced: 2016-07-06 Type: Follow-on To be raised: TBD Shares: TBD Price prior: EUR0.99 Unde...